Picture of Transgene SA logo

TNG — Transgene SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Transgene Q1 Cash And Cash Equivalents At EUR 46.8 Mln

May 10 (Reuters) - Transgene SA  TRNG.PA :
    * TRANSGENE: Q1 2022 FINANCIAL POSITION AND BUSINESS UPDATE
    * EUR 46.8 MILLION IN CASH AND CASH EQUIVALENTS AS OF MARCH
31,
2022 - CONFIRMED FINANCIAL VISIBILITY UNTIL END OF 2023
    * ALL OF TRANSGENE’S PRECLINICAL AND CLINICAL ASSETS
PROGRESSED IN
LINE WITH EXPECTATIONS IN Q1 2022

Source text for Eikon:  ID:nBw5c67WDa 
Further company coverage:  TRNG.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587696600;))

Recent news on Transgene SA

See all news